{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Treatment of adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory inflammatory myofibroblastic tumor (IMT) that is ALK-positive",
    "geneContextQualifier": "ALK",
    "objectTherapeutic": "Crizotinib [Xalkori]"
}